Institutional Investors Control 79% of Stryker Corporation (NYSE:SYK) and Were Rewarded Last Week After Stock Increased 3.9%
Shares of Surgical Tool and Medical Instrument Stocks Are Trading Higher in Sympathy With Intuitive Surgical, Which Gained on Strong Q3 Earnings.
Stryker Corporation (SYK): AI-Driven Innovations and Strategic Acquisitions Boost Growth
Truist Financial Maintains Stryker Corp(SYK.US) With Hold Rating, Announces Target Price $370
Express News | Treace Medical Concepts Inc - Expects Adjusted Ebitda Breakeven in 2025
Express News | Treace Medical Concepts Inc - Expects 2024 Adjusted Ebitda to Improve 50% Compared to 2023
Treace Files Patent Infringement and Unfair Competition Suit Against Stryker to Protect Lapiplasty Bunion Technology
BTIG Maintains Stryker Corp(SYK.US) With Buy Rating, Raises Target Price to $383
RBC Capital Maintains Stryker Corp(SYK.US) With Buy Rating, Maintains Target Price $386
Some Confidence Is Lacking In Stryker Corporation's (NYSE:SYK) P/E
Here's How Much $100 Invested In Stryker 10 Years Ago Would Be Worth Today
Goldman Sachs Adjusts Price Target on Stryker to $377 From $364
Wells Fargo's 'Core' Stocks: GOOGL, HD, KO, and More
ResMed Stock Is Surging. Expect More Gains for the Medical Equipment Maker. -- Barrons.com
Stryker to Announce Its Third Quarter 2024 Financial Results
Stryker Is Maintained at Outperform by Evercore ISI Group
Stryker Analyst Ratings
Evercore Maintains Stryker Corp(SYK.US) With Buy Rating, Raises Target Price to $380
Stryker Completes Acquisition of Vertos Medical, Inc., Expanding Interventional Pain Management Solutions
Piper Sandler Maintains Stryker Corp(SYK.US) With Buy Rating, Maintains Target Price $380